XHXiaozhou He

Xiaozhou He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaozhou He has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2016
      • Vol. 62  (3)

    Comparison of Tolerogenic Dendritic Cells Induced by Liver X Receptor Agonist from Bone Marrow-derived Cells and Natural Tolerogenic Dendritic Cells.

    by Haiyan Xu, Xuyi Ma, Dan Song, Ng Xue, Xiaozhou He, Xueguang Zhang

    • 1 December 2014
      • Vol. 20  (12) , 1090-2

    [Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication].

    by Tao Ding, Xiao-Zhou He, Xian-Lin Xu, Hai-Yan Xu, Cui-Xing Zhou, Yu-Ji Wang

    To investigate the expression of follistatin-like protein 1 (FSTL-1) in bone metastasis of prostate cancer (BMPC), the correlation of serum FSTL-1 with the chronic inflammatory factor interleukin-6 (IL-6) and bone morphogenetic protein 6 (BMP6) , and the clinical application value of serum FSTL-1 in BMPC. Using ELISA, we measured the expression levels of serum FSTL-1, IL-6, and BMP6 in 35 patients with BMPC and another 30 with benign prostatic hyperplasia (BPH) and performed correlation analysis on the data obtained. Compared with the BPH controls, the BMPC patients showed a significantly decreased expression of serum FSTL-1 ([34.45 ± 12.35] μg/L vs [20.23 ± 8.69] μg/L, P < 0.01) and increased levels of IL-6 ([11.21 ± 8.62] μg/L vs [23.56 ± 20.12] μg/L, P < 0.05) and BMP6 ([293.50 ± 39.72] μg/L vs [428.30 ± 178.40] μg/L, P < 0.05). There was a significant negative correlation between the level of serum FSTL-1 and those of IL-6 and BMP6 in the BMPC patients, with correlation coefficients of -0.971 and -0.972, respectively (P < 0.05). The expression of serum FSTL-1 decreases in patients with bone metastasis of prostate cancer, and it is correlated with the levels of inflammatory factor and cell transformation factor. This finding offers a novel biological marker for the development and progression of prostate cancer as well as a new biological target factor for its intervention.


    • 1 January 2012
      • Vol. 58, 411-8

    CD256 can be found in antibody-mediated renal allograft rejection tissues.

    by Haiyan Xu, Xiaozhou He, Wei Zhao, Hui Guo, Qianqian Shi, Yibei Zhu, Xueguang Zhang

    CD256 and CD257 belong to the TNFSF (Tumor necrosis factor superfamily), share closest homology structure, and can form functional heterotrimers. They may be involved in the progression of SLE (Systemic lupus erythematosus), RA (Rheumatoid arthritis), and other autoimmune disorders. In this present study, CD256 and some related molecules were detected and were investigated regarding the potential role of the CD256 signal during the development of renal allograft rejection. In 2009, 46 cases of renal allografts were collected, excised for evaluation of dysfunction, and 10 renal protocol biopsies with normal renal function were controlled. Immunohistochemistry (IHC) staining was applied to detect CD256, CD257, C4d, CD138 and other related molecules. HistoQuest Analysis software and SPSS16.0 were used to read and analyse the results. Pathological diagnosis was made according to Banff 2005 guidelines: antibody-mediated rejection (ABMR) 15 cases, T-cell-mediated rejection (TCMR) 16 cases, and 15 unknown aetiology cases (UAC). IHC results showed that CD256, CD257, and receptors for B cell activating factor receptor (BAFF-R), B cell maturation antigen (BCMA), and transmembrane activator calcium modulator, and cyclophilin ligand interactor (TACI) were expressed on the membrane/cytoplasm of renal tubular epithelial cells (RTEC) in the ABMR and TCMR group, while these molecules were not or weakly expressed in UAC and protocol biopsies. CD257 strong staining could be seen in ABMR, CD256 strong staining in both BCMR and TCMR, and there was statistical significance compared with other groups (p < 0.05). The receptors BAFF-R, BCMA, and TACI all strongly stained in ABMR, TACI also stained strongly in TCMR, and there was statistical significance compared with other groups (p < 0.05). The CD138+ molecule could be found in the renal interstitium and membrane/cytoplasm of RTEC, the CD138 mean expression in ABMR was statistically higher than other groups (p < 0.05). The correlation analysis indicated that CD256 significantly correlated with BCMA, TACI, and CD138, while CD257 significantly correlated with BAFF-R, BCMA, TACI, and CD138. CD256 can be found in ABMR tissues and may participate in the progression of ABMR together with CD257.


  • The Abnormal High Expression of B Cell Activating Factor Belonging to TNF Superfamily (BAFF) and Its Potential Role in Kidney Transplant Recipients

    by Haiyan Xu, Xiaozhou He, Qing Liu, Yingdi Chen, Yibei Zhu, Dan Shi, Xueguang Zhang

    B cell activating factor belonging to TNF superfamily (BAFF) is a critical regulator of B cell maturation and survival. In this present study, the expression characteristic of BAFF in kidney transplantation recipients was investigated, its potential significance was analyzed and peripheral blood of follow-up kidney transplant recipients was studied. Flow cytometric assay results showed that, cell-surface BAFF was significantly highly expressed on peripheral CD3+ T lymphocytes in 5 yrs group of kidney transplant recipients, compared with other groups (p < 0.05). BAFF expression could be found on CD4+ T cells and CD8+ T cells. The BAFF mRNA levels in peripheral mononuclear cells were consistent with the protein levels. However, serum soluble BAFF levels were interindividually different in each group. Stratified by renal function, it was found that cell-surface BAFF levels were significantly higher in those with abnormal renal function, compared with recipients with normal renal function (p < 0.05). ELISA assay results showed that expression levels of cell surface BAFF were significantly correlated with anti-HLA I & II antibodies. These results indicate that BAFF may be involved in the development of graft-loss and influences the long-time outcome of kidney allograft, likely mediated by interfering with immune response.